Learn more

RP BIO INC

Overview
  • Total Patents
    12
  • GoodIP Patent Rank
    141,545
  • Filing trend
    ⇩ 100.0%
About

RP BIO INC has a total of 12 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2016. It filed its patents most often in Republic of Korea. Its main competitors in its focus markets pharmaceuticals, machines and medical technology are SCHERER CORP R P, SWISS CAPS RECHTE & LIZENZEN and GUANGXI YUYUAN PHARMACEUTICAL CO LTD.

Patent filings in countries

World map showing RP BIO INCs patent filings in countries
# Country Total Patents
#1 Republic of Korea 12

Patent filings per year

Chart showing RP BIO INCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Kim Nam Ki 10
#2 Sim Hyeong Soo 8
#3 Sung Ha Chang 8
#4 Kwac Jin Bae 6
#5 Jung Taek Goon 5
#6 Bae Mun Hyoung 4
#7 Song Ji Young 3
#8 Kim June Ho 3
#9 Kim Sun Hyoung 1
#10 Park Sang Hoon 1

Latest patents

Publication Filing date Title
KR102222271B1 Solubilized composition of fexofenadine
KR102213669B1 Solubilized composition of caffeine
KR102076831B1 Tablet composition derived from natural material for water-based coating and vegetable water-based coating tablet using the same
KR102041534B1 Wedge Segment for producing medical capsule and apparatus for producing medical capsule having different diameters of the rollers
KR102063676B1 Die roller having clamping edge and apparatus for producing medical capsule having the same
KR102041532B1 Wedge Segment for producing medical capsule and apparatus for producing medical capsule having the same
KR102041535B1 Die roller for producing medical capsule with blade having different profile and apparatus for producing medical capsule having the same
KR102041533B1 Die roller for producing medical capsule with blade having groove and apparatus for producing medical capsule having the same
KR102050069B1 Formulation for soft capsules having improved stability and soft capsules comprising the same
KR102050070B1 Oil based composition having oxidation stability and soft capsules comprising the same
KR20190008795A Enteric soft capsule gel mass composition and enteric soft capsule using the same
KR101746500B1 Loratadine composition for soft capsule formulation and soft capsule containing the same